Allurion Technologies Inc. (ALUR)

USD 0.31

(-1.65%)

Total Debt Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual total debt in 2023 was 41.85 Million USD , down -29.69% from previous year.
  • Allurion Technologies Inc.'s latest quarterly total debt in 2024 Q2 was 43.58 Million USD , up 4.32% from previous quarter.
  • Allurion Technologies Inc. reported annual total debt of 59.53 Million USD in 2022, up 127.71% from previous year.
  • Allurion Technologies Inc. reported annual total debt of 26.14 Million USD in 2021, up 15278.24% from previous year.
  • Allurion Technologies Inc. reported quarterly total debt of 43.58 Million USD for 2024 Q2, up 4.32% from previous quarter.
  • Allurion Technologies Inc. reported quarterly total debt of 61.06 Million USD for 2023 Q3, down -20.82% from previous quarter.

Annual Total Debt Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Total Debt of Allurion Technologies Inc. (2023 - 2020)

Year Total Debt Total Debt Growth
2023 41.85 Million USD -29.69%
2022 59.53 Million USD 127.71%
2021 26.14 Million USD 15278.24%
2020 170 Thousand USD 0.0%

Peer Total Debt Comparison of Allurion Technologies Inc.

Name Total Debt Total Debt Difference
Abbott Laboratories 15.87 Billion USD 99.736%
Artivion, Inc. 359.34 Million USD 88.352%
Avanos Medical, Inc. 209.1 Million USD 79.982%
Butterfly Network, Inc. 25.02 Million USD -67.247%
Butterfly Network, Inc. 25.02 Million USD -67.247%
Bio-Rad Laboratories, Inc. 1.4 Billion USD 97.023%
Boston Scientific Corporation 9.49 Billion USD 99.559%
Perspective Therapeutics, Inc. - USD -Infinity%
CONMED Corporation 991.25 Million USD 95.777%
Edwards Lifesciences Corporation 694.9 Million USD 93.977%
Paragon 28, Inc. 112.03 Million USD 62.638%
Glaukos Corporation 383.73 Million USD 89.092%
Globus Medical, Inc. 520.4 Million USD 91.957%
Inspire Medical Systems, Inc. 24.84 Million USD -68.466%
Integer Holdings Corporation 1.04 Billion USD 95.979%
Medtronic plc 26.04 Billion USD 99.839%
Nevro Corp. 221.82 Million USD 81.131%
Owlet, Inc. 15.21 Million USD -175.085%
Penumbra, Inc. 234.34 Million USD 82.139%
Vicarious Surgical Inc. 14.83 Million USD -182.207%
Smith & Nephew plc 3.08 Billion USD 98.643%
Sonendo, Inc. 40.35 Million USD -3.732%
STERIS plc 3.38 Billion USD 98.763%
Stryker Corporation 12.99 Billion USD 99.678%
Vapotherm, Inc. 112.39 Million USD 62.758%
Zimmer Biomet Holdings, Inc. 5.99 Billion USD 99.302%